Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
SXT · NYSE · United States · Industrial Organic Chemicals
In shortSENSIENT TECHNOLOGIES CORP is profitable, generates cash and carries moderate debt, with revenue growing (+3.5% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 12.8% | 59/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 8.3% | 53/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 11.9% | 60/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 8.2% | 55/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 4.10× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.59× | 78/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 2.51× | 43/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 7.00× | 52/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 6.89 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 2.4% | 30/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.29× | 0/100 |
| Years with positive free cash flow (last 5) | 4 of 5 | 75/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 2.0% | 100/100 |
| Operating margin volatility | 1.1% | 99/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 3.9% | 38/100 |
|---|---|---|
| EPS growth, 3-year average | -1.8% | 16/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 1,380 | 1,437 | 1,456 | 1,557 | 1,612 |
| Cost of revenue | 926 | 948 | 996 | 1,050 | 1,073 |
| Gross profit | 455 | 489 | 460 | 507 | 539 |
| Research & development | 34 | 42 | 48 | 49 | 53 |
| Selling, general & admin | 285 | 292 | 305 | 316 | 332 |
| Operating income | 170 | 197 | 155 | 192 | 207 |
| Interest expense | 13 | 15 | 25 | 29 | 30 |
| Pre-tax income | 157 | 182 | 130 | 163 | 178 |
| Income tax | 39 | 41 | 36 | 38 | 43 |
| Net income | 119 | 141 | 93 | 125 | 134 |
| Diluted EPS | $2.81 | $3.34 | $2.21 | $2.94 | $3.16 |
| Diluted shares (millions) | 42 | 42 | 42 | 42 | 43 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
6.89 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 4, 2026